273 related articles for article (PubMed ID: 25467110)
1. Beyond BRCA: new hereditary breast cancer susceptibility genes.
Economopoulou P; Dimitriadis G; Psyrri A
Cancer Treat Rev; 2015 Jan; 41(1):1-8. PubMed ID: 25467110
[TBL] [Abstract][Full Text] [Related]
2. Hereditary breast cancer: the era of new susceptibility genes.
Apostolou P; Fostira F
Biomed Res Int; 2013; 2013():747318. PubMed ID: 23586058
[TBL] [Abstract][Full Text] [Related]
3. Hereditary Breast Cancer: BRCA Mutations and Beyond.
Patel MM; Adrada BE
Radiol Clin North Am; 2024 Jul; 62(4):627-642. PubMed ID: 38777539
[TBL] [Abstract][Full Text] [Related]
4. Mainstreaming genetic testing of cancer predisposition genes.
Rahman N
Clin Med (Lond); 2014 Aug; 14(4):436-9. PubMed ID: 25099850
[No Abstract] [Full Text] [Related]
5. Genetics of breast cancer: a topic in evolution.
Shiovitz S; Korde LA
Ann Oncol; 2015 Jul; 26(7):1291-9. PubMed ID: 25605744
[TBL] [Abstract][Full Text] [Related]
6. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
Maxwell KN; Wubbenhorst B; D'Andrea K; Garman B; Long JM; Powers J; Rathbun K; Stopfer JE; Zhu J; Bradbury AR; Simon MS; DeMichele A; Domchek SM; Nathanson KL
Genet Med; 2015 Aug; 17(8):630-8. PubMed ID: 25503501
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer genes: looking for BRACA's lost brother.
Cornejo-Moreno BA; Uribe-Escamilla D; Salamanca-Gómez F
Isr Med Assoc J; 2014 Dec; 16(12):787-92. PubMed ID: 25630211
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of genetic mutations in breast cancer.
Sheikh A; Hussain SA; Ghori Q; Naeem N; Fazil A; Giri S; Sathian B; Mainali P; Al Tamimi DM
Asian Pac J Cancer Prev; 2015; 16(6):2177-85. PubMed ID: 25824734
[TBL] [Abstract][Full Text] [Related]
10. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
Aloraifi F; Boland MR; Green AJ; Geraghty JG
Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
[TBL] [Abstract][Full Text] [Related]
11. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
Prakash R; Zhang Y; Feng W; Jasin M
Cold Spring Harb Perspect Biol; 2015 Apr; 7(4):a016600. PubMed ID: 25833843
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Grant RC; Selander I; Connor AA; Selvarajah S; Borgida A; Briollais L; Petersen GM; Lerner-Ellis J; Holter S; Gallinger S
Gastroenterology; 2015 Mar; 148(3):556-64. PubMed ID: 25479140
[TBL] [Abstract][Full Text] [Related]
13. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
[TBL] [Abstract][Full Text] [Related]
14. Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.
Nguyen-Dumont T; Hammet F; Mahmoodi M; Tsimiklis H; Teo ZL; Li R; Pope BJ; Terry MB; Buys SS; Daly M; Hopper JL; Winship I; Goldgar DE; Park DJ; Southey MC
Breast Cancer Res Treat; 2015 Jan; 149(2):547-54. PubMed ID: 25575445
[TBL] [Abstract][Full Text] [Related]
15. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Toss A; Tomasello C; Razzaboni E; Contu G; Grandi G; Cagnacci A; Schilder RJ; Cortesi L
Biomed Res Int; 2015; 2015():341723. PubMed ID: 26075229
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.
Bernier J; Poortmans P
Breast; 2015 Apr; 24(2):100-6. PubMed ID: 25557581
[TBL] [Abstract][Full Text] [Related]
17. Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice.
Doherty J; Bonadies DC; Matloff ET
J Genet Couns; 2015 Aug; 24(4):683-7. PubMed ID: 25475920
[TBL] [Abstract][Full Text] [Related]
18. PALB2 and the risks for cancer: implications for clinical care.
Smith EC
Oncol Nurs Forum; 2015 Jan; 42(1):100-2. PubMed ID: 25542327
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Drooger JC; Hooning MJ; Seynaeve CM; Baaijens MH; Obdeijn IM; Sleijfer S; Jager A
Cancer Treat Rev; 2015 Feb; 41(2):187-96. PubMed ID: 25533736
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing for RAD51C mutations: in the clinic and community.
Sopik V; Akbari MR; Narod SA
Clin Genet; 2015 Oct; 88(4):303-12. PubMed ID: 25470109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
